Background: The central mound technique offers a relatively less common approach for breast reduction. This study evaluated the expected safety and efficacy outcomes using this technique in a large patient series. Methods: A retrospective review of all patients undergoing central mound breast reduction at the authors’ institution between June of 1999 and November of 2018 was performed. Both bilateral macromastia and unilateral symmetrizing reduction patients were included but evaluated separately for some outcomes. Patient demographics and comorbidities, operative details, postoperative adverse events, and BREAST-Q scores were recorded. Associations between preoperative variables and outcomes were assessed with chi-square tests, Wilcoxon tests, and Kendall tau-b correlations. Results: A total of 325 patients were identified for inclusion (227 bilateral and 98 unilateral; 552 breasts). The average patient age was 46 years, and the average body mass index was 27.4 kg/m2. Among the bilateral macromastia patients, the average operative time was 3 hours 34 minutes, and average breast tissue removed was 533 g (right breast) and 560 g (left breast). Among all patients, average follow-up was 169 days. On a per-breast basis for all patients, the following complication rates were observed: seroma, 0.2 percent; hematoma, 1.1 percent; dehiscence, 2.9 percent; infection, 1.5 percent; hypertrophic scar, 4.6 percent; nipple necrosis, 0.4 percent; fat necrosis, 0.9 percent; and skin flap necrosis, 1.7 percent. Using the BREAST-Q Reduction/Mastopexy questions on a Likert scale ranging from 1 to 5, restricted to the bilateral macromastia patient population, all scores improved with statistical significance. Conclusion: The central mound pedicle is a safe and effective approach for reduction mammaplasty for both bilateral macromastia patients and unilateral symmetrizing operations. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
Sygnathia, or fusion of the jaw, is a rare condition in children, occurring either in isolation or as part of a larger overall syndrome. Consequences of this bony fusion may range from feeding difficulties to a complete inability to protect the airway. Owing to the uncommon nature of this problem and the high recurrence of bony fusion, standardized treatment protocols do not yet exist, making individual reports particularly useful for guiding the first-time management of such patients. In this report, we describe the case of a male infant with complete bony fusion of the right zygomatic maxillary complex to the mandible. Fusion was separated by osteotomy, repair of soft tissue with acellular dermal matrix/grafting, and plate separation. Serial jaw manipulation and operative stretching was necessary to prevent refusion of syngnathia even in the long term.
Purpose: Current guidelines recommend that open reduction internal fixation (ORIF) for distal radius fractures (DRFs) be performed within 4 weeks of injury. Delayed DRF management (4 weeks or more) is traditionally subject to corrective osteotomy. We report a 5-year single-surgeon series of delayed DRFs that were treated by ORIF rather than osteotomy. Methods: We performed a retrospective review on all patients admitted to a single tertiary care center with a DRF requiring ORIF (2007e2012). Institutional review board approval was obtained. Patients were divided into an early group (EG) (surgery less than 4 weeks after injury) and delayed group (DG) (surgery after 4 or more weeks). Data collected included demographics, injury pattern, intraoperative parameters, and pre-and postoperative x-ray findings. Subjective and objective functional data were determined using a Disabilities of the Arm, Shoulder, and Hand questionnaire score and Mayo Wrist Score. Results: A total of 171 patients (EG ¼ 54; DG ¼ 117) underwent ORIF from 2007 to 2012 and met inclusion criteria. Both groups had similar age, gender, and racial demographics. Of these, 117 patients in the delayed group underwent ORIFs at 40 ± 13.9 days (range, 28e146 days) after injury. Preoperative fracture patterns were radiographically equivalent. A dorsal approach was required more frequently in the EG (7.4%) compared with DG (1.1%). The Orbay maneuver was performed at a significantly higher rate in the DG (55.8%) compared with the EG (38.8%). Blood loss, tourniquet times, intraoperative complications, radiographic parameters, articular incongruency rates, and Disabilities of the Arm, Shoulder, and Hand score, and Mayo Wrist Score were not statistically significant between groups. Conclusions: No significant differences were found in intraoperative technique, operative time, postoperative radiographs, and subjective outcome measures in patients treated with early versus late ORIF. Despite the current belief that primary ORIF in delayed DRF is technically impossible and warrants an osteotomy, our series indicates that ORIF is indeed a viable option in DRFs as late as 5 months after injury. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Distal radius fractures (DRFs) are the most common fractures presenting to the emergency department worldwide and comprise almost one-sixth of all fracture cases. 1 The goal of DRF management is to obtain accurate anatomic reduction and fracture stabilization in the short term, with minimal degenerative changes and adequate pain-free motion, allowing return to preinjury activities in the long term. Closed reduction and casting is a mainstay of treatment for DRF, and multiple variables must be considered in determining surgical indications. 1 These include patient factors, fracture alignment (both before and after reduction), radiographic and clinical features of instability, and the presence of associated injuries. 2 In particular, time since injury is an important c...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.